Imaging Immune Activation in HIV by PET-MR
Clinical trial NCT03684655 · RECRUITING
Trial details
- NCT number
- NCT03684655
- Sponsor
- CellSight Technologies, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-21
- Primary completion
- 2025-10-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.